DOCS
Doximity, Inc.
Price Chart
Latest Quote
$20.46
+0.01 (+0.05%)
Current Price
| Previous Close | $20.45 |
| Open | $20.39 |
| Day High | $20.76 |
| Day Low | $19.79 |
| Volume | 2,486,858 |
Stock Information
| Shares Outstanding | 131.98M |
| Total Debt | $10.19M |
| Cash Equivalents | $748.60M |
| Revenue | $644.86M |
| Net Income | $196.05M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $3.74B |
| P/E Ratio | 20.88 |
| EPS (TTM) | $0.98 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.00B |
| Sales | $644.86M |
| Income | $196.05M |
| Book/sh | $5.19 |
| Cash/sh | $5.67 |
| Employees | 880 |
Financial Ratios
| Quick Ratio | 5.81 |
| Current Ratio | 6.09 |
| Debt/Eq | 1.07 |
| EPS Growth TTM | -69.40% |
Returns & Margins
| ROA | 11.61% |
| ROE | 19.28% |
| Gross Margin | 89.09% |
| Operating Margin | 21.58% |
| Profit Margin | 30.40% |
Ownership
| Insider Ownership | 3.21% |
| Institutional Ownership | 99.25% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 12.82 |
| PEG | 0.59 |
| P/S | 5.80 |
| P/B | 3.94 |
Analyst Data
| Recommendation | buy |
| Target Price | $25.42 |
Technical Indicators
| SMA20 | $20.58 |
| SMA50 | $22.29 |
| SMA200 | $40.78 |
| RSI | 41.13 |
| ATR | 0.8874 |
| Shares Float | 128.19M |
| Short Float | 12.70% |
| Short Ratio | 3.04 |
| Volatility | 1.29 |
| Rel Volume | 1.32 |
Performance History
| Week | +2.20% |
| Month | +6.23% |
| Quarter | -17.50% |
| 6 Months | -53.29% |
| YTD | -52.74% |
| Year | -65.03% |
| 3 Years | -36.99% |
| 10 Years | -61.40% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $20.46 | 4,484,100 |
| 2026-06-17 | $20.45 | 2,383,500 |
| 2026-06-16 | $20.89 | 2,348,200 |
| 2026-06-15 | $20.68 | 3,638,700 |
| 2026-06-12 | $20.04 | 2,286,900 |
| 2026-06-11 | $20.02 | 3,033,200 |
| 2026-06-10 | $20.24 | 3,963,800 |
| 2026-06-09 | $20.45 | 4,101,200 |
| 2026-06-08 | $20.30 | 2,789,400 |
| 2026-06-05 | $20.59 | 2,437,900 |
| 2026-06-04 | $20.70 | 3,743,400 |
| 2026-06-03 | $21.04 | 2,607,700 |
| 2026-06-02 | $21.51 | 3,203,200 |
| 2026-06-01 | $22.55 | 4,035,900 |
| 2026-05-29 | $21.40 | 4,093,400 |
| 2026-05-28 | $21.07 | 4,314,200 |
| 2026-05-27 | $20.26 | 3,806,500 |
| 2026-05-26 | $19.52 | 3,260,200 |
| 2026-05-22 | $19.94 | 3,475,100 |
| 2026-05-21 | $19.39 | 3,779,600 |
| 2026-05-20 | $19.86 | 4,502,700 |
| 2026-05-19 | $19.26 | 5,788,900 |
About Doximity, Inc.
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
đ° Latest News
Doximity (DOCS) Advances While Market Declines: Some Information for Investors
Zacks âĸ 2026-06-16T22:15:03Z
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?
Zacks âĸ 2026-06-12T15:30:03Z
Assessing Doximity (DOCS) Valuation After A Year Of Weak Share Price Performance
Simply Wall St. âĸ 2026-06-03T13:11:05Z
1 Profitable Stock to Keep an Eye On and 2 Facing Challenges
StockStory âĸ 2026-06-01T22:00:51Z
Workday and Doximity Shares Are Soaring, What You Need To Know
StockStory âĸ 2026-05-29T05:02:00Z
1 Cash-Producing Stock to Keep an Eye On and 2 We Brush Off
StockStory âĸ 2026-05-28T15:34:27Z
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
Zacks âĸ 2026-05-28T15:02:00Z
Doximity's (NYSE:DOCS) Soft Earnings Are Actually Better Than They Appear
Simply Wall St. âĸ 2026-05-26T10:23:44Z
1 Stock Under $50 on Our Watchlist and 2 Facing Headwinds
StockStory âĸ 2026-05-25T13:31:51Z
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?
Motley Fool âĸ 2026-05-24T16:50:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $70,326,000 | $55,874,000 | $50,669,000 | $53,490,000 |
| Cost Of Revenue | $70,326,000 | $55,874,000 | $50,669,000 | $53,490,000 |
| Total Revenue | $644,863,000 | $570,399,000 | $475,422,000 | $419,052,000 |
| Operating Revenue | $608,413,000 | $543,770,000 | $450,071,000 | $389,739,000 |
| Expenses | ||||
| Total Expenses | $429,943,000 | $340,295,000 | $303,608,000 | $293,944,000 |
| Other Income Expense | $-618,000 | $-2,382,000 | $-8,276,000 | $-1,239,000 |
| Other Non Operating Income Expenses | $-806,000 | $-247,000 | $62,000 | $-146,000 |
| Net Non Operating Interest Income Expense | $35,703,000 | $35,852,000 | $21,664,000 | $9,287,000 |
| Operating Expense | $359,617,000 | $284,421,000 | $252,939,000 | $240,454,000 |
| Selling And Marketing Expense | $163,648,000 | $145,713,000 | $133,129,000 | $123,523,000 |
| General And Administrative Expense | $65,267,000 | $45,670,000 | $37,827,000 | $36,745,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $196,051,000 | $223,185,000 | $147,582,000 | $112,818,000 |
| Net Interest Income | $35,703,000 | $35,852,000 | $21,664,000 | $9,287,000 |
| Interest Income | $35,703,000 | $35,852,000 | $21,664,000 | $9,287,000 |
| Normalized Income | $195,903,608 | $224,992,841 | $154,226,306 | $113,744,057 |
| Net Income From Continuing And Discontinued Operation | $196,051,000 | $223,185,000 | $147,582,000 | $112,818,000 |
| Total Operating Income As Reported | $214,920,000 | $227,800,000 | $163,878,000 | $125,108,000 |
| Net Income Common Stockholders | $196,051,000 | $223,185,000 | $147,582,000 | $112,818,000 |
| Net Income | $196,051,000 | $223,185,000 | $147,582,000 | $112,818,000 |
| Net Income Including Noncontrolling Interests | $196,051,000 | $223,185,000 | $147,582,000 | $112,818,000 |
| Net Income Continuous Operations | $196,051,000 | $223,185,000 | $147,582,000 | $112,818,000 |
| Pretax Income | $250,005,000 | $263,574,000 | $185,202,000 | $133,156,000 |
| Special Income Charges | $0 | $-2,304,000 | $-7,936,000 | $0 |
| Interest Income Non Operating | $35,703,000 | $35,852,000 | $21,664,000 | $9,287,000 |
| Operating Income | $214,920,000 | $230,104,000 | $171,814,000 | $125,108,000 |
| Gross Profit | $574,537,000 | $514,525,000 | $424,753,000 | $365,562,000 |
| Per Share | ||||
| Diluted EPS | $0.98 | $1.11 | $0.72 | $0.53 |
| Basic EPS | $1.05 | $1.19 | $0.78 | $0.58 |
| Other | ||||
| Tax Effect Of Unusual Items | $40,608 | $-327,159 | $-1,693,694 | $-166,943 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $229,115,000 | $242,898,000 | $190,417,000 | $136,484,000 |
| Total Unusual Items | $188,000 | $-2,135,000 | $-8,338,000 | $-1,093,000 |
| Total Unusual Items Excluding Goodwill | $188,000 | $-2,135,000 | $-8,338,000 | $-1,093,000 |
| Reconciled Depreciation | $14,383,000 | $10,659,000 | $10,265,000 | $10,283,000 |
| EBITDA (Bullshit earnings) | $229,303,000 | $240,763,000 | $182,079,000 | $135,391,000 |
| EBIT | $214,920,000 | $230,104,000 | $171,814,000 | $125,108,000 |
| Diluted Average Shares | $199,048,000 | $201,208,000 | $205,734,000 | $213,425,000 |
| Basic Average Shares | $187,014,000 | $186,841,000 | $190,172,000 | $193,176,000 |
| Diluted NI Availto Com Stockholders | $196,051,000 | $223,185,000 | $147,582,000 | $112,818,000 |
| Tax Provision | $53,954,000 | $40,389,000 | $37,620,000 | $20,338,000 |
| Gain On Sale Of Security | $188,000 | $169,000 | $-402,000 | $-1,093,000 |
| Research And Development | $130,702,000 | $93,038,000 | $81,983,000 | $80,186,000 |
| Selling General And Administration | $228,915,000 | $191,383,000 | $170,956,000 | $160,268,000 |
| Other Gand A | $65,267,000 | $45,670,000 | $37,827,000 | $36,745,000 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $0 |
| Restructuring And Mergern Acquisition | - | - | $7,936,000 | $0 |
| Gain On Sale Of Business | - | - | - | $0 |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $830,539,000 | $991,613,000 | $806,140,000 | $866,340,000 |
| Total Assets | $1,123,687,000 | $1,264,309,000 | $1,079,374,000 | $1,136,888,000 |
| Total Non Current Assets | $179,423,000 | $175,689,000 | $166,433,000 | $161,435,000 |
| Other Non Current Assets | $1,921,000 | $2,121,000 | $1,458,000 | $1,654,000 |
| Non Current Deferred Assets | $31,984,000 | $60,014,000 | $45,068,000 | $34,907,000 |
| Non Current Deferred Taxes Assets | $31,984,000 | $60,014,000 | $45,068,000 | $34,907,000 |
| Goodwill And Other Intangible Assets | $120,298,000 | $91,012,000 | $95,257,000 | $99,776,000 |
| Other Intangible Assets | $35,325,000 | $23,072,000 | $27,317,000 | $31,836,000 |
| Current Assets | $944,264,000 | $1,088,620,000 | $912,941,000 | $975,453,000 |
| Other Current Assets | $50,880,000 | $44,602,000 | $48,709,000 | $27,407,000 |
| Receivables | $144,783,000 | $128,354,000 | $101,332,000 | $107,047,000 |
| Accounts Receivable | $144,783,000 | $128,354,000 | $101,332,000 | $107,047,000 |
| Allowance For Doubtful Accounts Receivable | $-1,345,000 | $-1,937,000 | $-1,893,000 | $-887,000 |
| Gross Accounts Receivable | $146,128,000 | $130,291,000 | $103,225,000 | $107,934,000 |
| Cash Cash Equivalents And Short Term Investments | $748,601,000 | $915,664,000 | $762,900,000 | $840,999,000 |
| Cash And Cash Equivalents | $219,178,000 | $209,614,000 | $96,785,000 | $158,027,000 |
| Current Deferred Assets | - | - | - | $5,118,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $10,185,000 | $12,396,000 | $14,546,000 | $15,637,000 |
| Long Term Debt And Capital Lease Obligation | $8,075,000 | $10,185,000 | $12,397,000 | $13,885,000 |
| Current Debt And Capital Lease Obligation | $2,110,000 | $2,211,000 | $2,149,000 | $1,752,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $172,850,000 | $181,684,000 | $177,977,000 | $170,772,000 |
| Total Non Current Liabilities Net Minority Interest | $17,877,000 | $25,427,000 | $30,727,000 | $31,265,000 |
| Other Non Current Liabilities | $9,402,000 | $14,962,000 | $18,119,000 | $17,182,000 |
| Non Current Deferred Liabilities | $400,000 | $280,000 | $211,000 | $198,000 |
| Current Liabilities | $154,973,000 | $156,257,000 | $147,250,000 | $139,507,000 |
| Other Current Liabilities | $14,844,000 | $11,475,000 | $14,277,000 | $11,332,000 |
| Current Deferred Liabilities | $106,050,000 | $114,285,000 | $99,145,000 | $105,238,000 |
| Payables And Accrued Expenses | $31,558,000 | $27,699,000 | $31,183,000 | $20,596,000 |
| Payables | $10,020,000 | $2,713,000 | $16,271,000 | $2,776,000 |
| Total Tax Payable | $6,011,000 | $1,357,000 | $14,018,000 | $1,504,000 |
| Income Tax Payable | $1,787,000 | $0 | - | - |
| Accounts Payable | $4,009,000 | $1,356,000 | $2,253,000 | $1,272,000 |
| Equity | ||||
| Common Stock Equity | $950,837,000 | $1,082,625,000 | $901,397,000 | $966,116,000 |
| Total Equity Gross Minority Interest | $950,837,000 | $1,082,625,000 | $901,397,000 | $966,116,000 |
| Stockholders Equity | $950,837,000 | $1,082,625,000 | $901,397,000 | $966,116,000 |
| Gains Losses Not Affecting Retained Earnings | $28,000 | $1,323,000 | $-2,664,000 | $-14,083,000 |
| Other Equity Adjustments | $28,000 | $1,323,000 | $-2,664,000 | $-14,083,000 |
| Retained Earnings | $-51,062,000 | $186,888,000 | $79,989,000 | $217,855,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $183,059,646 | $188,875,301 | $186,561,649 | $193,941,000 |
| Share Issued | $183,059,646 | $188,875,301 | $186,561,649 | $193,941,000 |
| Tangible Book Value | $830,539,000 | $991,613,000 | $806,140,000 | $866,340,000 |
| Invested Capital | $950,837,000 | $1,082,625,000 | $901,397,000 | $966,116,000 |
| Working Capital | $789,291,000 | $932,363,000 | $765,691,000 | $835,946,000 |
| Capital Lease Obligations | $10,185,000 | $12,396,000 | $14,546,000 | $15,637,000 |
| Total Capitalization | $950,837,000 | $1,082,625,000 | $901,397,000 | $966,116,000 |
| Additional Paid In Capital | $1,001,688,000 | $894,225,000 | $823,885,000 | $762,150,000 |
| Capital Stock | $183,000 | $189,000 | $187,000 | $194,000 |
| Common Stock | $183,000 | $189,000 | $187,000 | $194,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $400,000 | $280,000 | $211,000 | $198,000 |
| Long Term Capital Lease Obligation | $8,075,000 | $10,185,000 | $12,397,000 | $13,885,000 |
| Current Deferred Revenue | $106,050,000 | $114,285,000 | $99,145,000 | $105,238,000 |
| Current Capital Lease Obligation | $2,110,000 | $2,211,000 | $2,149,000 | $1,752,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $411,000 | $587,000 | $496,000 | $589,000 |
| Current Accrued Expenses | $21,538,000 | $24,986,000 | $14,912,000 | $17,820,000 |
| Goodwill | $84,973,000 | $67,940,000 | $67,940,000 | $67,940,000 |
| Net PPE | $25,220,000 | $22,542,000 | $24,650,000 | $25,098,000 |
| Accumulated Depreciation | $-31,332,000 | $-24,947,000 | $-19,079,000 | $-13,575,000 |
| Gross PPE | $56,552,000 | $47,489,000 | $43,729,000 | $38,673,000 |
| Leases | $816,000 | $816,000 | $992,000 | $888,000 |
| Other Properties | $7,140,000 | $8,886,000 | $12,332,000 | $13,819,000 |
| Machinery Furniture Equipment | $48,596,000 | $37,787,000 | $30,405,000 | $23,966,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $529,423,000 | $706,050,000 | $666,115,000 | $682,972,000 |
| Construction In Progress | - | - | - | $20,405,000 |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $317,495,000 | $266,740,000 | $178,295,000 | $173,418,000 |
| Operating Activities | ||||
| Operating Cash Flow | $326,458,000 | $273,265,000 | $184,096,000 | $179,602,000 |
| Cash Flow From Continuing Operating Activities | $326,458,000 | $273,265,000 | $184,096,000 | $179,602,000 |
| Operating Gains Losses | - | - | $402,000 | $1,093,000 |
| Investing Activities | ||||
| Capital Expenditure | $-8,963,000 | $-6,525,000 | $-5,801,000 | $-6,184,000 |
| Investing Cash Flow | $147,170,000 | $-29,298,000 | $31,186,000 | $-59,923,000 |
| Cash Flow From Continuing Investing Activities | $147,170,000 | $-29,298,000 | $31,186,000 | $-59,923,000 |
| Net Other Investing Changes | - | - | - | - |
| Capital Expenditure Reported | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-431,652,000 | $-120,293,000 | $-280,716,000 | $-85,324,000 |
| Financing Cash Flow | $-464,064,000 | $-131,138,000 | $-276,524,000 | $-74,461,000 |
| Cash Flow From Continuing Financing Activities | $-464,064,000 | $-131,138,000 | $-276,524,000 | $-74,461,000 |
| Net Other Financing Charges | $-46,088,000 | $-34,146,000 | $-12,146,000 | $-3,822,000 |
| Net Common Stock Issuance | $-431,652,000 | $-120,293,000 | $-280,716,000 | $-85,324,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| Income Tax Paid Supplemental Data | $21,814,000 | $55,654,000 | $51,274,000 | $5,231,000 |
| End Cash Position | $219,178,000 | $209,614,000 | $96,785,000 | $158,027,000 |
| Beginning Cash Position | $209,614,000 | $96,785,000 | $158,027,000 | $112,809,000 |
| Changes In Cash | $9,564,000 | $112,829,000 | $-61,242,000 | $45,218,000 |
| Proceeds From Stock Option Exercised | $13,676,000 | $23,301,000 | $16,338,000 | $14,685,000 |
| Common Stock Payments | $-431,652,000 | $-120,293,000 | $-280,716,000 | $-85,324,000 |
| Net Investment Purchase And Sale | $182,661,000 | $-22,773,000 | $36,987,000 | $-239,000 |
| Sale Of Investment | $571,820,000 | $652,784,000 | $509,854,000 | $190,321,000 |
| Purchase Of Investment | $-389,159,000 | $-675,557,000 | $-472,867,000 | $-190,560,000 |
| Net Business Purchase And Sale | $-26,528,000 | $0 | $0 | $-53,500,000 |
| Purchase Of Business | $-26,528,000 | $0 | $0 | $-53,500,000 |
| Net Intangibles Purchase And Sale | $-8,963,000 | $-6,525,000 | $-5,654,000 | $-4,483,000 |
| Purchase Of Intangibles | $-8,963,000 | $-6,525,000 | $-5,654,000 | $-4,483,000 |
| Net PPE Purchase And Sale | $0 | $0 | $-147,000 | $-1,701,000 |
| Purchase Of PPE | $0 | $0 | $-147,000 | $-1,701,000 |
| Change In Working Capital | $-45,699,000 | $-24,097,000 | $-24,524,000 | $-21,033,000 |
| Change In Other Working Capital | $-22,605,000 | $3,159,000 | $-14,688,000 | $9,065,000 |
| Change In Other Current Liabilities | $-2,211,000 | $-2,149,000 | $-1,678,000 | $-213,000 |
| Change In Payables And Accrued Expense | $4,268,000 | $-663,000 | $8,332,000 | $-195,000 |
| Change In Payable | $4,268,000 | $-663,000 | $8,332,000 | $-195,000 |
| Change In Account Payable | $4,268,000 | $-663,000 | $8,332,000 | $-195,000 |
| Change In Prepaid Assets | $-8,272,000 | $2,762,000 | $-20,483,000 | $-3,448,000 |
| Change In Receivables | $-16,879,000 | $-27,206,000 | $3,993,000 | $-26,242,000 |
| Changes In Account Receivables | $-16,879,000 | $-27,206,000 | $3,993,000 | $-26,242,000 |
| Other Non Cash Items | $15,539,000 | $12,075,000 | $13,528,000 | $13,359,000 |
| Stock Based Compensation | $121,627,000 | $72,386,000 | $51,076,000 | $47,834,000 |
| Asset Impairment Charge | $0 | $2,304,000 | $0 | $0 |
| Amortization Of Securities | $-7,581,000 | $-11,655,000 | $-5,238,000 | $3,115,000 |
| Deferred Tax | $32,138,000 | $-11,592,000 | $-8,593,000 | $13,226,000 |
| Deferred Income Tax | $32,138,000 | $-11,592,000 | $-8,593,000 | $13,226,000 |
| Depreciation Amortization Depletion | $14,383,000 | $10,659,000 | $10,265,000 | $10,283,000 |
| Depreciation And Amortization | $14,383,000 | $10,659,000 | $10,265,000 | $10,283,000 |
| Net Income From Continuing Operations | $196,051,000 | $223,185,000 | $147,582,000 | $112,818,000 |
| Gain Loss On Investment Securities | - | - | $402,000 | $1,093,000 |
| Sale Of Business | - | - | - | $0 |
| Gain Loss On Sale Of Business | - | - | - | $0 |
| Change In Other Current Assets | - | - | - | - |
| Change In Accrued Expense | - | - | - | - |
Fetched: 2026-06-16